Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus inf...
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-[alpha] and ribavirin treatment: potential role as markers of response to antiviral therapy
About this item
Full title
Author / Creator
Publisher
Milano: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Milano: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
The serum levels of soluble HLA class I antigens (sHLA-A, -B, -C and sHLA-G) were determined in 40 HCV genotype 1-infected patients before (T 0), after 3, 6, and 12 months (T 3, T 6, and T 12) of pegylated-IFN-[alpha] plus ribavirin therapy and 6 months (T 18) after the end of treatment. Twenty patients were sustained virological responders (SVR),...
Alternative Titles
Full title
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-[alpha] and ribavirin treatment: potential role as markers of response to antiviral therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1865259562
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1865259562
Other Identifiers
ISSN
1591-8890
E-ISSN
1591-9528
DOI
10.1007/s10238-015-0399-5
